<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; } .font16 { font-size : 16; } .font17 { font-size : 17; } .font19 { font-size : 19; } .font20 { font-size : 20; } .font21 { font-size : 21; } .font25 { font-size : 25; } .font30 { font-size : 30; }</style>
 <body>
  <p>
   <span class="font30">patients </span>
   <span class="font25">fatty </span>
   <span class="font21">dialysis </span>
   <span class="font20">acid </span>
   <span class="font19">total </span>
   <span class="font19">studies </span>
   <span class="font17">blood </span>
   <span class="font17">reported </span>
   <span class="font16">PUFA </span>
   <span class="font16">erythrocyte </span>
   <span class="font16">acid; </span>
   <span class="font16">levels </span>
   <span class="font15">acids </span>
   <span class="font15">Total </span>
   <span class="font15">mortality </span>
   <span class="font14">hemodialysis </span>
   <span class="font14">N/A </span>
   <span class="font14">USA </span>
   <span class="font14">Japan </span>
   <span class="font14">plasma </span>
   <span class="font14">serum </span>
   <span class="font14">study </span>
   <span class="font13">Erythrocyte </span>
   <span class="font13">risk </span>
   <span class="font13">associated </span>
   <span class="font13">profile </span>
   <span class="font13">Friedman </span>
   <span class="font13">all-cause </span>
   <span class="font13">composition </span>
   <span class="font13">polyunsaturated </span>
   <span class="font13">status </span>
   <span class="font13">DHA </span>
   <span class="font13">Nutr. </span>
   <span class="font13">chronic </span>
   <span class="font13">{border-style </span>
   <span class="font13">Kim </span>
   <span class="font13">dietary </span>
   <span class="font13">healthy </span>
   <span class="font13">n-, </span>
   <span class="font12">Korea </span>
   <span class="font12">lower </span>
   <span class="font12">omega- </span>
   <span class="font12">px;} </span>
   <span class="font12">#ffffff;} </span>
   <span class="font12">disease </span>
   <span class="font12">Clin. </span>
   <span class="font12">EPA </span>
   <span class="font12">INT </span>
   <span class="font12">PUFA, </span>
   <span class="font12">data </span>
   <span class="font12">circulating </span>
   <span class="font12">clinical </span>
   <span class="font12">kidney </span>
   <span class="font12">Italy </span>
   <span class="font12">Ren. </span>
   <span class="font12">Table </span>
   <span class="font12">essential </span>
   <span class="font12">higher </span>
   <span class="font12">membrane </span>
   <span class="font12">MUFA </span>
   <span class="font12">reporting </span>
   <span class="font12">review </span>
   <span class="font11">Am. </span>
   <span class="font11">patients, </span>
   <span class="font11">France </span>
   <span class="font11">MUFA, </span>
   <span class="font11">Nephrol. </span>
   <span class="font11">Serbia </span>
   <span class="font11">included </span>
   <span class="font11">index </span>
   <span class="font11">low </span>
   <span class="font11">observed </span>
   <span class="font11">patients. </span>
   <span class="font11">(.–.) </span>
   <span class="font11">America </span>
   <span class="font11">Dialysis </span>
   <span class="font11">EPA, </span>
   <span class="font11">HD, </span>
   <span class="font11">Hamazaki </span>
   <span class="font11">TAG </span>
   <span class="font11">cardiac </span>
   <span class="font11">compared </span>
   <span class="font11">profiles </span>
   <span class="font11">renal </span>
   <span class="font11">sudden </span>
   <span class="font11">./j.jrn... </span>
   <span class="font11">Australia </span>
   <span class="font11">Blood </span>
   <span class="font11">DHA, </span>
   <span class="font11">Fatty </span>
   <span class="font11">GC-FID </span>
   <span class="font11">However, </span>
   <span class="font11">Kidney </span>
   <span class="font11">Lee </span>
   <span class="font11">Peuchant </span>
   <span class="font11">SFA, </span>
   <span class="font11">Son </span>
   <span class="font11">South </span>
   <span class="font11">cardiovascular </span>
   <span class="font11">increased </span>
   <span class="font11">n-), </span>
   <span class="font11">peritoneal </span>
   <span class="font11">A.N. </span>
   <span class="font11">B.A. </span>
   <span class="font11">CI: </span>
   <span class="font11">Huang </span>
   <span class="font11">Int. </span>
   <span class="font11">North </span>
   <span class="font11">PL, </span>
   <span class="font11">Therefore, </span>
   <span class="font11">Watkins </span>
   <span class="font11">associations </span>
   <span class="font11">docosahexaenoic </span>
   <span class="font11">eicosapentaenoic </span>
   <span class="font11">intake </span>
   <span class="font11">proportions </span>
   <span class="font11">px; </span>
   <span class="font11">significantly </span>
   <span class="font11">treatment </span>
   <span class="font11">{font-family </span>
   <span class="font11">(.–.%) </span>
   <span class="font11">(HR: </span>
   <span class="font11">AA, </span>
   <span class="font11">CI) </span>
   <span class="font11">Data </span>
   <span class="font11">Europe </span>
   <span class="font11">S.M. </span>
   <span class="font11">[], </span>
   <span class="font11">biomarkers </span>
   <span class="font11">controls </span>
   <span class="font11">events </span>
   <span class="font11">font-size </span>
   <span class="font11">haemodialysis </span>
   <span class="font11">increase </span>
   <span class="font11">inflammation </span>
   <span class="font11">inflammatory </span>
   <span class="font11">oxidative </span>
   <span class="font11">patients: </span>
   <span class="font11">presented </span>
   <span class="font11">reduced </span>
   <span class="font11">supplementation </span>
   <span class="font11">systematic </span>
   <span class="font11">uremic </span>
   <span class="font11">vs. </span>
   <span class="font10">(.–.%), </span>
   <span class="font10">Africa </span>
   <span class="font10">Asia </span>
   <span class="font10">CE, </span>
   <span class="font10">CKD </span>
   <span class="font10">Comparison </span>
   <span class="font10">Denmark </span>
   <span class="font10">FAs </span>
   <span class="font10">GLC </span>
   <span class="font10">LA, </span>
   <span class="font10">Lipid </span>
   <span class="font10">Marangoni </span>
   <span class="font10">PUFAs </span>
   <span class="font10">Park </span>
   <span class="font10">Poland </span>
   <span class="font10">Res. </span>
   <span class="font10">Study </span>
   <span class="font10">Turkey </span>
   <span class="font10">United </span>
   <span class="font10">W.S. </span>
   <span class="font10">Yoshimoto-Furuie </span>
   <span class="font10">articles </span>
   <span class="font10">consumption </span>
   <span class="font10">coronary </span>
   <span class="font10">deficiency </span>
   <span class="font10">double; </span>
   <span class="font10">duplicate </span>
   <span class="font10">effects </span>
   <span class="font10">evidence </span>
   <span class="font10">fish </span>
   <span class="font10">individual </span>
   <span class="font10">meta-analysis </span>
   <span class="font10">metabolism </span>
   <span class="font10">monounsaturated </span>
   <span class="font10">oil </span>
   <span class="font10">outcomes </span>
   <span class="font10">plasma, </span>
   <span class="font10">publications </span>
   <span class="font10">published </span>
   <span class="font10">ratio </span>
   <span class="font10">related </span>
   <span class="font10">search </span>
   <span class="font10">stress </span>
   <span class="font10">(.%) </span>
   <span class="font10">(.–.), </span>
   <span class="font10">.–.) </span>
   <span class="font10">Bae </span>
   <span class="font10">CVD </span>
   <span class="font10">Carrero </span>
   <span class="font10">Dial. </span>
   <span class="font10">Dis. </span>
   <span class="font10">Effects </span>
   <span class="font10">J.J. </span>
   <span class="font10">Med. </span>
   <span class="font10">Nutrients </span>
   <span class="font10">OA, </span>
   <span class="font10">Plasma </span>
   <span class="font10">SFA </span>
   <span class="font10">Shoji </span>
   <span class="font10">States </span>
   <span class="font10">Stenvinkel </span>
   <span class="font10">Sweden </span>
   <span class="font10">TAG, </span>
   <span class="font10">Transpl. </span>
   <span class="font10">analysis </span>
   <span class="font10">association </span>
   <span class="font10">available </span>
   <span class="font10">biomarker </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">death </span>
   <span class="font10">different </span>
   <span class="font10">endpoints </span>
   <span class="font10">factors </span>
   <span class="font10">failure </span>
   <span class="font10">linoleic </span>
   <span class="font10">lipid </span>
   <span class="font10">long-chain </span>
   <span class="font10">nutritional </span>
   <span class="font10">oleic </span>
   <span class="font10">only, </span>
   <span class="font10">percentage </span>
   <span class="font10">present </span>
   <span class="font10">protein </span>
   <span class="font10">relative </span>
   <span class="font10">solid; </span>
   <span class="font10">stage </span>
   <span class="font10">vascular </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">&amp;gt;.–. </span>
   <span class="font10">(&amp;gt;.%) </span>
   <span class="font10">(i) </span>
   <span class="font10">(ii) </span>
   <span class="font10">(iii) </span>
   <span class="font10">(year) </span>
   <span class="font10">./S-()- </span>
   <span class="font10">./j.-...x </span>
   <span class="font10">ALA, </span>
   <span class="font10">Abbreviations: </span>
   <span class="font10">Association </span>
   <span class="font10">C-reactive </span>
   <span class="font10">Clinical </span>
   <span class="font10">DPA </span>
   <span class="font10">Effect </span>
   <span class="font10">FA, </span>
   <span class="font10">GC-MS </span>
   <span class="font10">Health </span>
   <span class="font10">Heimbürger </span>
   <span class="font10">Lindholm </span>
   <span class="font10">Peck </span>
   <span class="font10">Perunicic-Pekovic </span>
   <span class="font10">Ristic-Medic </span>
   <span class="font10">S.E. </span>
   <span class="font10">Sertoglu </span>
   <span class="font10">Studies </span>
   <span class="font10">Svensson </span>
   <span class="font10">Talwalker </span>
   <span class="font10">Y.K. </span>
   <span class="font10">acid, </span>
   <span class="font10">additional </span>
   <span class="font10">adrenic </span>
   <span class="font10">adults </span>
   <span class="font10">arachidonic </span>
   <span class="font10">baseline </span>
   <span class="font10">bold </span>
   <span class="font10">calcification </span>
   <span class="font10">cell </span>
   <span class="font10">cohort </span>
   <span class="font10">concentrations </span>
   <span class="font10">controlled </span>
   <span class="font10">courier; </span>
   <span class="font10">docosapentaenoic </span>
   <span class="font10">em; </span>
   <span class="font10">end-stage </span>
   <span class="font10">focused </span>
   <span class="font10">follow-up </span>
   <span class="font10">followed </span>
   <span class="font10">gas </span>
   <span class="font10">greater </span>
   <span class="font10">implications </span>
   <span class="font10">intervention </span>
   <span class="font10">inversely </span>
   <span class="font10">involved </span>
   <span class="font10">markers </span>
   <span class="font10">mechanisms </span>
   <span class="font10">median </span>
   <span class="font10">modification </span>
   <span class="font10">novel </span>
   <span class="font10">nutrients---t_Table </span>
   <span class="font10">odds </span>
   <span class="font10">performed </span>
   <span class="font10">pilot </span>
   <span class="font10">populations </span>
   <span class="font10">pre-dialysis </span>
   <span class="font10">proportion </span>
   <span class="font10">prospective </span>
   <span class="font10">pt;} </span>
   <span class="font10">reported. </span>
   <span class="font10">research </span>
   <span class="font10">review, </span>
   <span class="font10">risks </span>
   <span class="font10">sample </span>
   <span class="font10">saturated </span>
   <span class="font10">shown </span>
   <span class="font10">studies, </span>
   <span class="font10">type </span>
   <span class="font10">undergoing </span>
   <span class="font10">used </span>
   <span class="font10">vintage </span>
   <span class="font10">years </span>
   <span class="font10">α-linolenic </span>
  </p>
 </body>
</html>
